The report “Global Peripheral Artery Disease (PAD) Market Research”, has been prepared based on an in-depth market analysis with inputs from industry experts.
Scope of the Report
This report entitled Global Peripheral Artery Disease Market: Trends & Opportunities (2015-2020), analyses the global market for peripheral artery disease and the treatments available for it. The global peripheral artery disease market is analyzed by value, by number of people affected from PAD, PAD by prevalence, by treatment mix and by players in this market. This report also includes forecasting of peripheral artery disease market by value and by number of people affected for the years 2015-2020. The sizing and growth of global peripheral atherectomy market is provided in this report, which includes PAD atherectomy market by value and by players. The forecasting of PAD atherectomy market by value is also provided for the years 2015-2020.
This report includes the analysis of global peripheral artery disease device market by value and by product types. This segment of report also includes the sizing and growth of global PAD angioplasty market and global PAD stent market, with focus on drug coated balloons (DCB) market and drug eluting stents (DES) market.
Furthermore, this report also provides the analysis of United States peripheral artery disease market. The analysis includes the US PAD market by value and by treatment mix. This segment of report also includes the US PAD atherectomy market by value and by players and the US PAD drug coated balloons (DCB) market by value and by players.
To Get The Sample Copy Of This Report:http://www.marketresearchreports.biz/sample/sample/550827
Global peripheral artery disease market dynamics are also given in this report which includes the growth drivers, market trends and challenges faced by this market. Company profiling of three major players (Johnson & Johnson, Medtronic Inc. and Stryker Corporation) of peripheral artery disease market is done in this report. Company profiling includes business overview, financial overview and business strategies of each company.
Johnson & Johnson
Peripheral artery disease (PAD) is a medical condition in which arteries become narrow due to build-up of plague on the vessel walls. Peripheral artery disease affects the arteries of arms, legs or neuro-vasculature, other than those that supply the heart and brain.
Peripheral artery disease is also known as Peripheral Vascular Disease (PVD) and Peripheral Artery Occlusive Disease. Plaque that deposits in the arteries is made up of fats, cholesterol, calcium, fibrous tissue and other substances in the blood. Plaque formations can grow large enough to significantly reduce the blood’s flow through an artery.
Treatment of Peripheral artery disease requires multiple approaches, depending on the individual patient. There are two main approaches for the treatment of PAD. The first approach is endovascular treatment, which includes stenting, ballooning and atherectomy. These different treatments can also be used in combination, such as atherectomy with stenting. The second approach is surgical treatment, which includes bypass surgery and amputation.
The global peripheral artery disease market has increased with a healthy growth rate in 2014 and is expected to increase further in coming years. The main driving forces for PAD market are increasing population, especially the age group of 65 and above, rising global healthcare expenditure, technological advancements and favorable reimbursement rates for PAD treatment. Yet there are some challenges which PAD industry faces such as restenosis (re-occurrence of PAD post treatment), inappropriate diagnosis and limitations of existing devices.
To View The Latest Industry Press Releases:http://www.marketresearchreports.biz/pressreleases